MPO and coronary artery disorder: We found a weak inverse association between MPO-DNA complex levels and a history of CHD (β -0.10 mAU/mL, 95% CI -0.17;-0.03), the use of lipid-lowering drugs (β -0.06 mAU/mL, 95% CI -0.12;-0.01), and HDL (β -0.07 mAU/mL/ mmol/L, 95% CI -0.12;-0.03) (Table 2).